Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Crystal Watson, Arie Barlev, Jodie Worrall, Steve Duff & Rachel Beckerman. (2021) Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients. Journal of Drug Assessment 10:1, pages 18-26.
Read now
Read now
Philipp Zimmer, Andreas Mierau, Wilhelm Bloch, Heiko K. Strüder, Thorben Hülsdünker, Alexander Schenk, Leonie Fiebig, Freek T. Baumann, Moritz Hahn, Nina Reinart, Michael Hallek & Thomas Elter. (2015) Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leukemia & Lymphoma 56:2, pages 347-352.
Read now
Read now
Ann S. Hamilton. (2011) Quality of life research: adding an important dimension to the evaluation of therapeutic outcomes. Leukemia & Lymphoma 52:3, pages 353-354.
Read now
Read now
Articles from other publishers (11)
Rebecca Cheng, Kayla Scippa, Frederick L. Locke, Julia Thornton Snider & Heather Jim. (2021) Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study. Oncology and Therapy 10:1, pages 123-141.
Crossref
Crossref
Alexandra-Cristina Paunescu, Christiane Bergman Copie, Sandra Malak, Steven Le Gouill, Vincent Ribrag, Krimo Bouabdallah, David Sibon, Gerhard Rumpold, Marie Preau, Nicolas Mounier, Corinne Haioun, Fabrice Jardin & Caroline Besson. (2021) Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study. Annals of Hematology 101:2, pages 317-332.
Crossref
Crossref
Donald L. Patrick, Annette Powers, Monika Parisi Jun, Yeonhee Kim, Jacob Garcia, Christine Dehner & David G. Maloney. (2021) Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma. Blood Advances 5:8, pages 2245-2255.
Crossref
Crossref
Richard T. MaziarzEdmund K. Waller, Ulrich Jaeger, Isabelle FleuryJoseph McGuirk, Harald Holte, Samantha Jaglowski, Stephen J. SchusterMichael R. BishopJason R. Westin, Stephan Mielke, Takanori Teshima, Veronika BachanovaStephen R. FoleyPeter BorchmannGilles A. Salles, Jie ZhangRanjan Tiwari, Lida B. Pacaud, Qiufei MaConstantine S. Tam. (2020) Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Advances 4:4, pages 629-637.
Crossref
Crossref
Carrie A. Thompson, Kathleen J. Yost, Matthew J. Maurer, Cristine Allmer, Umar Farooq, Thomas M. Habermann, David J. Inwards, William R. Macon, Brian K. Link, Allison C. Rosenthal & James R. Cerhan. (2018) Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma. Hematological Oncology 36:5, pages 749-756.
Crossref
Crossref
Daren Chircop & Josianne Scerri. (2018) The lived experience of patients with non-Hodgkin's lymphoma undergoing chemotherapy. European Journal of Oncology Nursing 35, pages 117-121.
Crossref
Crossref
Daren Chircop & Josianne Scerri. (2017) Coping with non-Hodgkin’s lymphoma: a qualitative study of patient perceptions and supportive care needs whilst undergoing chemotherapy. Supportive Care in Cancer 25:8, pages 2429-2435.
Crossref
Crossref
Rosanna Tarricone, Dana Abu Koush, Barbara Nyanzi-Wakholi & Antonieta Medina-Lara. (2016) A systematic literature review of the economic implications of chemotherapy-induced diarrhea and its impact on quality of life. Critical Reviews in Oncology/Hematology 99, pages 37-48.
Crossref
Crossref
Soo Hyun Kim, Im-Ryung Kim, So Hee Kim, Suyeon Lee, Onam Ok, Won Seog Kim, Cheolwon Suh & Moon Hee Lee. (2014) Health-related quality of life in Korean lymphoma survivors compared with the general population. Annals of Hematology 93:9, pages 1531-1540.
Crossref
Crossref
Sophie Lee, Angela Knox, Irene S. L. Zeng, Christin Coomarasamy, Hilary Blacklock & Samar Issa. (2012) Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis. Supportive Care in Cancer 21:3, pages 841-846.
Crossref
Crossref
Fay J. Hlubocky, Kimberly Webster, John Cashy, Jennifer Beaumont & David Cella. (2013) The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym). Lymphoma 2013, pages 1-9.
Crossref
Crossref